Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.

作者: Ibrahim F Benter , Mariam H M Yousif , Fatemah M Al-Saleh , Raj Raghupathy , Mark C Chappell

DOI: 10.1097/FJC.0B013E31821324B6

关键词: Internal medicineCardiac function curveEndocrinologyNitric oxideCaptoprilPerfusionMedicineAngiotensin IIIschemiaHydralazineBlood pressure

摘要: We assessed the contribution of angiotensin-(1-7) [Ang-(1-7)] to captopril-induced cardiovascular protection in spontaneously hypertensive rats (SHRs) chronically treated with nitric oxide synthesis inhibitor NG-nitro-L-arginine methyl ester (SHR-l). (80 mg/L) administration for 3 weeks increased mean arterial pressure (MAP) from 196 ± 6 229 mm Hg (P < 0.05). Treatment SHR-l Ang-(1-7) antagonist [d-Ala7]-Ang-(1-7) (A779; 744 μg·kg(-1)·d(-1) ip) further elevated MAP 253 0.05 vs or SHR). Moreover, A779 treatment attenuated reduction and proteinuria by either captopril (300 mg/L drinking water) hydralazine (1.5 mg·kg(-1)·d(-1) ip). In isolated perfused hearts, recovery left ventricular function global ischemia was enhanced exacerbated A779. The beneficial effects on cardiac function. Recovery also improved hearts acutely during both perfusion reperfusion periods. acute reduced actions improve after ischemia. conclude that periods availability, endogenous plays a protective role effectively buffering increase blood renal injury contributes lowering tissue model severe hypertension end-organ damage.

参考文章(42)
Robson A. S. Santos, Anderson J. Ferreira, Ana Cristina Simões e Silva, Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Experimental Physiology. ,vol. 93, pp. 519- 527 ,(2008) , 10.1113/EXPPHYSIOL.2008.042002
Shridhar N. Iyer, Kazuo Yamada, Debra I. Diz, Carlos M. Ferrario, Mark C. Chappell, Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. Journal of Cardiovascular Pharmacology. ,vol. 36, pp. 109- 117 ,(2000) , 10.1097/00005344-200007000-00015
Andreas Daiber, Matthias Oelze, Meike Coldewey, K. Kaiser, C. Huth, S. Schildknecht, M. Bachschmid, Y. Nazirisadeh, V. Ullrich, A. Mülsch, T. Münzel, N. Tsilimingas, Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure Biochemical and Biophysical Research Communications. ,vol. 338, pp. 1865- 1874 ,(2005) , 10.1016/J.BBRC.2005.10.106
G F DiBona, S Y Jones, Arterial baroreceptor reflex function in borderline hypertensive rats. Hypertension. ,vol. 19, pp. 56- 61 ,(1992) , 10.1161/01.HYP.19.1.56
Ibrahim F. Benter, Mariam H.M. Yousif, Gursev S. Dhaunsi, Jaspal Kaur, Mark C. Chappell, Debra I. Diz, Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. American Journal of Nephrology. ,vol. 28, pp. 25- 33 ,(2008) , 10.1159/000108758
Robson A. S. Santos, Ana C. Simoes e Silva, Christine Maric, Denise M. R. Silva, Raquel Pillar Machado, Insa de Buhr, Silvia Heringer-Walther, Sergio Veloso B. Pinheiro, Myriam Teresa Lopes, Michael Bader, Elizabeth P. Mendes, Virgina Soares Lemos, Maria Jose Campagnole-Santos, Heinz-Peter Schultheiss, Robert Speth, Thomas Walther, Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas Proceedings of the National Academy of Sciences of the United States of America. ,vol. 100, pp. 8258- 8263 ,(2003) , 10.1073/PNAS.1432869100
TanYa M. Gwathmey, Hossam A. Shaltout, Karl D. Pendergrass, Nancy T. Pirro, Jorge P. Figueroa, James C. Rose, Debra I. Diz, Mark C. Chappell, Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production American Journal of Physiology-renal Physiology. ,vol. 296, ,(2009) , 10.1152/AJPRENAL.90766.2008
K Yamamoto, M C Chappell, K B Brosnihan, C M Ferrario, In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension. ,vol. 19, pp. 692- 696 ,(1992) , 10.1161/01.HYP.19.6.692
Vinayak Shenoy, Anderson J. Ferreira, Yanfei Qi, Rodrigo A. Fraga-Silva, Carlos Díez-Freire, Autumn Dooies, Joo Yun Jun, Srinivas Sriramula, Nithya Mariappan, Dorna Pourang, Changaram S. Venugopal, Joseph Francis, Timothy Reudelhuber, Robson A. Santos, Jawaharlal M. Patel, Mohan K. Raizada, Michael J. Katovich, The Angiotensin-Converting Enzyme 2/Angiogenesis-(1–7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension American Journal of Respiratory and Critical Care Medicine. ,vol. 182, pp. 1065- 1072 ,(2010) , 10.1164/RCCM.200912-1840OC
Horacio Vidrio, Gabriela Fernández, Martha Medina, Ezequiel Alvarez, Francisco Orallo, Effects of hydrazine derivatives on vascular smooth muscle contractility, blood pressure and cGMP production in rats: comparison with hydralazine. Vascular Pharmacology. ,vol. 40, pp. 13- 21 ,(2003) , 10.1016/S1537-1891(02)00312-9